๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

SAFETY AND EFFICACY OF ITRACONAZOLE FOR THE TREATMENT OF ONYCHOMYCOSIS IN THE DIABETIC POPULATION

โœ Scribed by Won-Young Chey; Young-Gull Kim; Eui-Chang Chung; Ai-Young Lee


Book ID
108913971
Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
134 KB
Volume
45
Category
Article
ISSN
0933-7407

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Continuous and intermittent itraconazole
โœ HAVU; BRANDT; HEIKKILร„; HOLLMEN; OKSMAN; RANTANEN; SAARI; STUBB; TURJANMAA; PIEP ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 783 KB

This multicentre, double-blind, randomized study compared the pharmacokinetics of itraconazole given at 200 mg once daily for 3 months and intermittently at 200 mg twice daily for 1 week per month followed by a 3-week drug-free period for 3 months in the treatment of onychomycosis. Patients were fol

L.I.ON. Study: efficacy and tolerability
โœ Sigurgeirsson; Billstein; Rantanen; Ruzicka; Di Fonzo; Vermeer; Goodfield; Evans ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 415 KB

We undertook a prospective, randomised, double-blind, double-dummy, multicentre, parallel-group study to compare the efficacy and tolerability of continuous terbinafine (Lamisil) with intermittent itraconazole (Sporanox) in the treatment of toenail onychomycosis. A total of 496 patients (age range 1